Lifshitz Law PLLC Announces Investigations of MGP Ingredients, Inc. (NASDAQ: MGPI), Integral Ad Science Holding Corp. (NASDAQ: IAS), TransMedics Group, Inc. (NASDAQ: TMDX), and Semtech Corporation (NASDAQ: SMTC)

NEW YORK CITY, NY / ACCESS Newswire / August 22, 2025 / MGP Ingredients, Inc. (NASDAQ:MGPI) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose material information. Sales of hard liquors, such […]

BHVN Deadline: BHVN Investors with Losses in Excess of $100K Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the “Class Period”), of the important September 12, 2025 lead plaintiff deadline. https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg So What: If you purchased Biohaven securities during the Class Period you may

IRBT Deadline: IRBT Investors with Losses in Excess of $100K Have Opportunity to Lead iRobot Corporation Securities Fraud Lawsuit

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofiRobot Corporation (NASDAQ: IRBT) between January 29, 2024 and March 11, 2025, both dates inclusive (the “Class Period”), of the important September 5, 2025 lead plaintiff deadline. So What: If you purchased iRobot securities during the Class Period you may

WAMCO Deadline: Western Asset Management Company, LLC Mutual Fund Investors with Losses in Excess of $100K Have Opportunity to Lead Western Asset Management Company Securities Fraud Lawsuit

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the “Western Asset US Core Bond Fund” mutual fund classes – Class I (ticker: “WATFX”), Class A (ticker: “WABAX”), Class C (ticker: “WABCX”), Class FI (ticker: “WAPIX”) Class IS (ticker: “WACSX”), and Class R (ticker: “WABRX”) – and the “Western Asset

Commercial National Financial Corporation Announces Quarterly Dividend & Share Repurchase Program

(PinkSheets:CEFC),(Pinksheets:CEFC), Quarterly DividendITHACA, Mich., Aug. 22, 2025 (GLOBE NEWSWIRE) — Commercial National Financial Corporation (OTCID: CEFC) announced that the Board of Directors declared a regular quarterly cash dividend of 14 cents per share. The dividend is payable October 1, 2025 to shareholders of record on September 19, 2025. Based on a recent closing price of

Commercial National Financial Corporation Announces Quarterly Dividend & Share Repurchase Program

Commercial National Financial Corporation Announces Quarterly Dividend & Share Repurchase Program GlobeNewswire August 22, 2025 Quarterly DividendITHACA, Mich., Aug. 22, 2025 (GLOBE NEWSWIRE) — Commercial National Financial Corporation (OTCID: CEFC) announced that the Board of Directors declared a regular quarterly cash dividend of 14 cents per share. The dividend is payable October 1, 2025 to

Levi & Korsinsky Moves to SueWallSt for Snap Inc. Investors That Lost Money

NEW YORK, NY / ACCESS Newswire / August 22, 2025 / – SueWallSt: Class Action Filed Against Snap Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between April 29, 2025 and August 5, 2025. If you suffered

SRPT Deadline: SRPT Investors with Losses in Excess of $100K Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline. So What: If you purchased Sarepta Therapeutics securities during the Class Period

Scroll to Top